Ovarian CancerReferencesCitationsWooster R, Weber BL (2003). Breast and ovarian cancer.
New England Journal of Medicine, 348(23):
2339–2347. Ozols RF, et al. (2005). Epithelial ovarian cancer. In
WJ Hoskins et al., eds., Principles and Practice of Gynecologic
Oncology, 4th ed., chap. 25, pp. 895–987. Philadelphia: Lippincott
Williams and Wilkins. Karlan BY, et al. (2005). Ovarian cancer, peritoneal
carcinoma, and fallopian tube carcinoma. In VT DeVita Jr et al., eds.,
Cancer: Principles and Practice of Oncology, 7th ed.,
vol. 1, pp. 1364–1397. Philadelphia: Lippincott Williams and Wilkins.
Brennan K, et al. (2007). Premalignant and malignant
disorders of the ovaries and oviducts. In AH DeCherney et al., eds.,
Current Diagnosis and Treatment Obstetrics and
Gynecology, 10th ed., pp. 971–884. New York: McGraw-Hill. National Cancer Institute (2002). Genetic testing for
BRCA1 and BRCA2: It's your choice. Available online:
http://www.cancer.gov/cancertopics/factsheet/Risk/BRCA. Zografos GC, et al. (2004). Common risk factors of
breast and ovarian cancer: recent view. International Journal
of Gynecological Cancer, 14: 721–740. Speroff L, Fritz MA (2005). Postmenopausal hormone
therapy. In Clinical Gynecologic Endocrinology and
Infertility, 7th ed., pp. 689–777. Philadelphia: Lippincott Williams and
Wilkins. Beral V, et al. (2007). Ovarian cancer and hormone
replacement therapy in the Million Women Study. Lancet,
369(9574): 1703–1710. Edmondson RJ, Monaghan JM (2001). The epidemiology of
ovarian cancer. International Journal of Gynecological
Cancer, 11: 423–429. Modugno F, et al. (2004). Oral contraceptive use,
reproductive history, and risk of epithelial ovarian cancer in women with and
without endometriosis. American Journal of Obstetricians and
Gynecologists, 191: 733–740. Fairfield KM, et al. (2004). A prospective study of
dietary lactose and ovarian cancer. International Journal of
Cancer, 110: 271–277. National Comprehensive Cancer Network (2007). Ovarian
cancer. Clinical Practice Guidelines in Oncology, version
1. Available online:
http://www.nccn.org/professionals/physician_gls/PDF/ovarian.pdf. U.S. Preventive Services Task Force (2004). Screening
for ovarian cancer. Available online:
http://www.ahrq.gov/clinic/uspstf/uspovar.htm. National Cancer Institute (2007). Genetics of Breast and Ovarian Cancer (PDQ)—Health
Professional Version. Available online:
http://www.cancer.gov/cancertopics/pdq/genetics/breast-and-ovarian/healthprofessional.
Trimbos JB, Timmers P (2004). Chemotherapy for early
ovarian cancer. Current Opinion in Obstetrics and
Gynecology, 16(1): 43–48. Armstrong DK, et al. (2006). Intraperitoneal cisplatin
and paclitaxel in ovarian cancer. New England Journal of
Medicine, 354(1): 34–43. Cannistra SA (2007). Gynecologic cancer. In DC Dale,
DD Federman, eds., ACP Medicine, section 12, chap. 10.
New York: WebMD. Lurie G, et al. (2007). Association of estrogen and
progestin potency of oral contraceptives with ovarian carcinoma risk.
Obstetrics and Gynecology, 109(3): 597–607. Deligeoroglou E, et al. (2003). Oral contraceptives
and reproductive system cancer. Annals of the New York Academy
of Sciences, 997: 199–208. American Cancer Society (2006). American Cancer Society's Detailed Guide: Ovarian Cancer.
Available online:
http://www.cancer.org/docroot/CRI/CRI_2_1x.asp?rnav=criov&dt=33. Kauff ND, et al. (2002). Risk-reducing
salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. New England Journal of Medicine, 346(21):
1609–1615. Berek JS (2002). Ovarian cancer. In JS Berek, ed.,
Novak's Gynecology, 13th ed., pp. 1245–1319.
Philadelphia: Lippincott Williams and Wilkins.
Other Works ConsultedChu CS, Rubin SC (2001). Second-look laparotomy for
epithelial ovarian cancer: A reappraisal. Current Oncology
Reports, 3(1): 11–18. National Cancer Institute (2006). Ovarian Epithelial Cancer (PDQ): Treatment—Health Professional
Version. Available online:
http://www.cancer.gov/cancertopics/pdq/treatment/ovarianepithelial/healthprofessional.
| |